1
|
Francesca S, Vitale L, Arena C, Raimondi G, Olivieri F, Cirillo V, Paradiso A, de Pinto MC, Maggio A, Barone A, Rigano MM. The efficient physiological strategy of a novel tomato genotype to adapt to chronic combined water and heat stress. Plant Biol (Stuttg) 2022; 24:62-74. [PMID: 34605594 PMCID: PMC9293464 DOI: 10.1111/plb.13339] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/17/2021] [Accepted: 08/26/2021] [Indexed: 05/28/2023]
Abstract
Climate change is increasing the frequency of high temperature shocks and water shortages, pointing to the need to develop novel tolerant varieties and to understand the mechanisms employed to withstand combined abiotic stresses. Two tomato genotypes, a heat-tolerant Solanum lycopersicum accession (LA3120) and a novel genotype (E42), previously selected as a stable yielding genotype under high temperatures, were exposed to single and combined water and heat stress. Plant functional traits, pollen viability and physiological (leaf gas exchange and chlorophyll a fluorescence emission measurements) and biochemical (antioxidant content and antioxidant enzyme activity) measurements were carried out. A Reduced Representation Sequencing approach allowed exploration of the genetic variability of both genotypes to identify candidate genes that could regulate stress responses. Both abiotic stresses had a severe impact on plant growth parameters and on the reproductive phase of development. Growth parameters and leaf gas exchange measurements revealed that the two genotypes used different physiological strategies to overcome individual and combined stresses, with E42 having a more efficient capacity to utilize the limiting water resources. Activation of antioxidant defence mechanisms seemed to be critical for both genotypes to counteract combined abiotic stresses. Candidate genes were identified that could explain the different physiological responses to stress observed in E42 compared with LA3120. Results here obtained have shown how new tomato genetic resources can be a valuable source of traits for adaptation to combined abiotic stresses and should be used in breeding programmes to improve stress tolerance in commercial varieties.
Collapse
Affiliation(s)
- S. Francesca
- Department of Agricultural SciencesUniversity of Naples “Federico II”PorticiItaly
| | - L. Vitale
- Department of Biology, Agriculture and Food SciencesNational Research CouncilInstitute for Agricultural and Forestry Systems in the MediterraneanPorticiItaly
| | - C. Arena
- Department of BiologyUniversity of Naples “Federico II”NaplesItaly
- BATCenter ‐ Interuniversity Center for Studies on Bioinspired Agro‐Environmental TechnologyPorticiItaly
| | - G. Raimondi
- Department of Agricultural SciencesUniversity of Naples “Federico II”PorticiItaly
| | - F. Olivieri
- Department of Agricultural SciencesUniversity of Naples “Federico II”PorticiItaly
| | - V. Cirillo
- Department of Agricultural SciencesUniversity of Naples “Federico II”PorticiItaly
| | - A. Paradiso
- Department of BiologyUniversity of Bari “Aldo Moro”BariItaly
| | - M. C. de Pinto
- Department of BiologyUniversity of Bari “Aldo Moro”BariItaly
| | - A. Maggio
- Department of Agricultural SciencesUniversity of Naples “Federico II”PorticiItaly
| | - A. Barone
- Department of Agricultural SciencesUniversity of Naples “Federico II”PorticiItaly
| | - M. M. Rigano
- Department of Agricultural SciencesUniversity of Naples “Federico II”PorticiItaly
| |
Collapse
|
2
|
Bresolin A, Maggio A, Landoni V, Cicchetti A, Trombetta L, Ferrari P, Moretti E, Giandini T, Petrucci E, Aimonetto S, Farina B, Carillo V, Cazzulo E, Pignoli E, Salmoiraghi P, Rancati T, Fiorino C, Cozzarini C. Dose-volume effect for acute patient-reported intestinal toxicity from whole pelvis radiotherapy: an Italian multicentric study. Phys Med 2021. [DOI: 10.1016/s1120-1797(22)00127-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
|
3
|
Miranti A, Bresciani S, Di Dia A, Maggio A, Stasi M. Changes in patient anatomy or setup: replanning predictive power of tomotherapy sinograms gamma analysis by using Delivery Analysis. Phys Med 2021. [DOI: 10.1016/s1120-1797(22)00159-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
|
4
|
Makrydimas G, Damiani G, Jakil C, Cigna V, Orlandi M, Picciotto F, Schillaci G, Cassarà F, Vinciguerra M, Leto F, Giambona A, Maggio A, Nicolaides KH. Reply. Ultrasound Obstet Gynecol 2020; 56:790-791. [PMID: 33136321 DOI: 10.1002/uog.23137] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Affiliation(s)
- G Makrydimas
- Department of Obstetrics and Gynecology, Ioannina University Hospital, Ioannina, Greece
| | - G Damiani
- UOS Medicina Fetale e Diagnosi Prenatale AOOR Villa Sofia Cervello, Palermo, Italy
| | - C Jakil
- UOS Medicina Fetale e Diagnosi Prenatale AOOR Villa Sofia Cervello, Palermo, Italy
| | - V Cigna
- UOS Medicina Fetale e Diagnosi Prenatale AOOR Villa Sofia Cervello, Palermo, Italy
| | - M Orlandi
- UOS Medicina Fetale e Diagnosi Prenatale AOOR Villa Sofia Cervello, Palermo, Italy
| | - F Picciotto
- UOS Medicina Fetale e Diagnosi Prenatale AOOR Villa Sofia Cervello, Palermo, Italy
| | - G Schillaci
- UOS Medicina Fetale e Diagnosi Prenatale AOOR Villa Sofia Cervello, Palermo, Italy
| | - F Cassarà
- Laboratory for Molecular Diagnosis of Rare Diseases, AOOR Villa Sofia Cervello, Palermo, Italy
| | - M Vinciguerra
- Laboratory for Molecular Diagnosis of Rare Diseases, AOOR Villa Sofia Cervello, Palermo, Italy
| | - F Leto
- Laboratory for Molecular Diagnosis of Rare Diseases, AOOR Villa Sofia Cervello, Palermo, Italy
| | - A Giambona
- Laboratory for Molecular Diagnosis of Rare Diseases, AOOR Villa Sofia Cervello, Palermo, Italy
| | - A Maggio
- Campus of Hematology Franco and Piera Cutino, AOOR Villa Sofia Cervello, Palermo, Italy
| | - K H Nicolaides
- Harris Birthright Research Centre for Fetal Medicine, King's College Hospital, London, UK
| |
Collapse
|
5
|
Makrydimas G, Damiani G, Jakil C, Cigna V, Orlandi M, Picciotto F, Schillaci G, Cassarà F, Vinciguerra M, Leto F, Giambona A, Maggio A, Nicolaides KH. Celocentesis for early prenatal diagnosis of hemoglobinopathy. Ultrasound Obstet Gynecol 2020; 56:672-677. [PMID: 32339311 DOI: 10.1002/uog.22059] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/03/2020] [Revised: 04/14/2020] [Accepted: 04/15/2020] [Indexed: 06/11/2023]
Abstract
OBJECTIVE Celocentesis is an invasive technique that can provide prenatal diagnosis of single-gene disorders, from as early as 7 weeks' gestation. The objective of this study was to examine the safety of celocentesis. METHODS In this prospective study, celocentesis was performed for prenatal diagnosis of hemoglobinopathy in 402 singleton pregnancies in which both parents were carriers of β-thalassemia or sickle cell disease trait. We assessed procedure-related maternal discomfort or pain, success of sampling and obtaining results, pregnancy outcome and postnatal follow-up. RESULTS First, celocentesis was carried out at a median gestational age of 8.6 (range, 6.9-9.9) weeks and celomic fluid was successfully aspirated in 99.8% of cases. Second, 67% of women had no or only mild discomfort, 18% had moderate discomfort, 12% had mild-to-moderate pain and 3% had severe pain. Third, prenatal diagnosis from analysis of the celomic fluid was successful in 93.8% cases, and in the last 121 cases, it was always successful. Fourth, in all cases of successful sampling and analysis of celomic fluid, the diagnosis was concordant with results obtained from additional prenatal or postnatal testing. Fifth, in addition to diagnosis of hemoglobinopathy, quantitative fluorescence polymerase chain reaction analysis, which was performed to evaluate maternal contamination using several markers for chromosomes X, Y, 21, 18 and 13, led to the accurate diagnosis of chromosomal aneuploidy. Sixth, in all cases of an affected fetus diagnosed by celocentesis in which the parents chose termination of pregnancy, this was carried out < 10 weeks' gestation. Seventh, in 97.1% (298/307) of the continuing pregnancies there was live birth, in seven (2.3%) there was miscarriage and in two (0.7%) there was loss to follow-up. Eighth, fetal abnormalities were diagnosed in three (1%) cases, including unilateral transverse amputation of the forearm, unilateral moderate hydronephrosis and small-bowel duplication. All neonates were examined by a pediatrician and were found to be phenotypically normal, except for the three cases with a prenatally diagnosed defect. CONCLUSIONS Celocentesis can be used for early prenatal diagnosis of genetic abnormalities, and the procedure-related risk of pregnancy complications appears to be low. Copyright © 2020 ISUOG. Published by John Wiley & Sons Ltd.
Collapse
Affiliation(s)
- G Makrydimas
- Department of Obstetrics and Gynecology, Ioannina University Hospital, Ioannina, Greece
| | - G Damiani
- UOS Medicina Fetale e Diagnosi Prenatale AOOR Villa Sofia Cervello, Palermo, Italy
| | - C Jakil
- UOS Medicina Fetale e Diagnosi Prenatale AOOR Villa Sofia Cervello, Palermo, Italy
| | - V Cigna
- UOS Medicina Fetale e Diagnosi Prenatale AOOR Villa Sofia Cervello, Palermo, Italy
| | - M Orlandi
- UOS Medicina Fetale e Diagnosi Prenatale AOOR Villa Sofia Cervello, Palermo, Italy
| | - F Picciotto
- UOS Medicina Fetale e Diagnosi Prenatale AOOR Villa Sofia Cervello, Palermo, Italy
| | - G Schillaci
- UOS Medicina Fetale e Diagnosi Prenatale AOOR Villa Sofia Cervello, Palermo, Italy
| | - F Cassarà
- Laboratory for Molecular Diagnosis of Rare Diseases, AOOR Villa Sofia Cervello, Palermo, Italy
| | - M Vinciguerra
- Laboratory for Molecular Diagnosis of Rare Diseases, AOOR Villa Sofia Cervello, Palermo, Italy
| | - F Leto
- Laboratory for Molecular Diagnosis of Rare Diseases, AOOR Villa Sofia Cervello, Palermo, Italy
| | - A Giambona
- Laboratory for Molecular Diagnosis of Rare Diseases, AOOR Villa Sofia Cervello, Palermo, Italy
| | - A Maggio
- Campus of Hematology Franco and Piera Cutino, AOOR Villa Sofia Cervello, Palermo, Italy
| | - K H Nicolaides
- Harris Birthright Research Centre for Fetal Medicine, King's College Hospital, London, UK
| |
Collapse
|
6
|
Di Dia A, Maggio A, Gabriele D, Cattari G, Bresciani S, Miranti A, Carillo V, D'Angelo S, Dall'Oglio S, Donato V, Ferrara T, Maluta S, Stasi M, Gabriele P. Quality indicators for hyperthermia treatment: Italian survey analysis. Phys Med 2020; 70:118-122. [PMID: 32007600 DOI: 10.1016/j.ejmp.2020.01.010] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/23/2019] [Revised: 01/08/2020] [Accepted: 01/09/2020] [Indexed: 12/15/2022] Open
Abstract
AIM Nowadays, no Quality Indicators (QI) have been proposed for Hyperthermia treatments. Starting from radiotherapy experience, the aim of this work is to adapt radiotherapy indicators to Hyperthermia and to propose a new specific set of QI in Hyperthermia field. MATERIAL AND METHODS At first, radiotherapy quality indicators published in literature have been adapted to hyperthermia setting. Moreover, new specific indicators for the treatment of hyperthermia have been defined. To obtain the standard reference values of quality indicators, a questionnaire was sent to 7 Italian hyperthermia Institutes with a list of questions on physical and clinical hyperthermia treatment in order to highlight the different therapeutic approaches. RESULTS Three structure, five process and two outcome QI were selected. It has been possible to adapt seven indicators from radiotherapy, while three indicators have been defined as new specific indicators for hyperthermia. Average values used as standard reference values have been obtained and proposed. CONCLUSION The survey performed on 7 Italian centres allowed to derive the standard reference value for each indicator. The proposed indicators are available to be investigated and applied by a larger number of Institutes in which hyperthermia treatment is performed in order to monitor the operational procedures and to confirm or modify the reference standard value derived for each indicator.
Collapse
Affiliation(s)
- A Di Dia
- Medical Physics Department, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Torino, Italy.
| | - A Maggio
- Medical Physics Department, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Torino, Italy
| | - D Gabriele
- Institute of Radiological Sciences, University of Sassari, Italy
| | - G Cattari
- Radiotherapy Department, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Torino, Italy
| | - S Bresciani
- Medical Physics Department, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Torino, Italy
| | - A Miranti
- Medical Physics Department, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Torino, Italy
| | - V Carillo
- Radiotherapy, Centro Aktis, Marano di Napoli, Italy
| | - S D'Angelo
- U.O. Unità Fegato, A.O. Moscati, Avellino, Italy
| | - S Dall'Oglio
- Radiation Oncology Department, University Hospital, Verona, Italy
| | - V Donato
- Radiotherapy Department, S. Camillo-Forlanini, Roma, Italy
| | - T Ferrara
- Radiotherapy Department, Oncologic Businco Hospital, Cagliari, Italy
| | - S Maluta
- Hyperthermia Service, Centro Medico Serena, Padova, Italy
| | - M Stasi
- Medical Physics Department, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Torino, Italy
| | - P Gabriele
- Radiotherapy Department, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Torino, Italy
| |
Collapse
|
7
|
Vitrano A, Ruffo GB, DʼAscola DG, Caruso V, Filosa A, Masera N, Pitrolo L, Rigano P, Cuccia L, Di Maggio R, Maggio A. LONG-TERM SEQUENTIAL DEFERIPRONE AND DEFERASIROX THERAPY IN TRANSFUSION-DEPENDENT THALASSEMIA PATIENTS: A PROSPECTIVE CLINICAL TRIAL. Hemasphere 2019. [DOI: 10.1097/02014419-201906001-00403] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
8
|
Miranti A, Bresciani S, Leone R, Maggio A, Di Dia A, Bracco C, Stasi M. 185. Characterization of TrueBeam STx for SRS/SBRT treatments with the new phantom StereoPHAN. Phys Med 2018. [DOI: 10.1016/j.ejmp.2018.04.196] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
9
|
Maggio A, Tamponi M, Gabriele D, Conti M, Meloni G, Gabriele P, Stasi M. 299. Prostate cancer dose-fraction sensitivity deduced from radiotherapy outcome of 17949 patients. Phys Med 2018. [DOI: 10.1016/j.ejmp.2018.04.308] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
10
|
Di Dia A, Bracco C, Bresciani S, Maggio A, A. Miranti, Cattari G, Gabriele P, Stasi M. 260. Quality indicators in hyperthermia treatment. Phys Med 2018. [DOI: 10.1016/j.ejmp.2018.04.270] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
11
|
Palorini F, Cicchetti A, Rancati T, Cozzarini C, Avuzzi B, Botti A, Cante D, Borca VC, Esposti CD, Garibaldi E, Girelli G, Iotti C, Maggio A, Munoz F, Palombarini M, Pierelli A, Pignoli E, Vavassori V, Valdagni R, Fiorino C. 47. Dependence from dose and fractionation of late severe urinary toxicities after radical radiotherapy for prostate cancer. Phys Med 2018. [DOI: 10.1016/j.ejmp.2018.04.057] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
12
|
Bresciani S, Cresto F, Di Dia A, Maggio A, Miranti A, Garibaldi E, Gabriele P, Stasi M. EP-1960: Implementation of a statistical ideal DVH for the evaluation and optimization of treatment plans. Radiother Oncol 2018. [DOI: 10.1016/s0167-8140(18)32269-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
13
|
Palorini F, Cicchetti A, Rancati T, Cozzarini C, Avuzzi B, Botti A, Cante D, Casanova Borca V, Degli Esposti C, Garibaldi E, Girelli G, Iotti C, Maggio A, Munoz F, Palombarini M, Pierelli A, Pignoli E, Vavassori V, Valdagni R, Fiorino C. PV-0320: NTCP models of late severe urinary symptoms after radical IMRT for prostate cancer. Radiother Oncol 2018. [DOI: 10.1016/s0167-8140(18)30630-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
14
|
Gabriele P, Avuzzi B, Sanguineti G, Maggio A, Giandini T, Landoni V, Munoz F, Migliaccio F, Cante D, Petrucci E, Vavassori V, Villa E, Waskiewicz J, Farina P, Farina B, Girelli G, Improta I, Badenchini F, Noris Chiorda B, Carillo V, Sini C, Valdagni R, Fiorino C, Rancati T, Cozzarini C. PO-0826: Factors affecting self-reported, long-term (1-2 yrs) urinary incontinence from post-prostatectomy RT. Radiother Oncol 2018. [DOI: 10.1016/s0167-8140(18)31136-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
15
|
Vinciguerra M, Passarello C, Cassarà F, Leto F, Cannata M, Calvaruso G, Renda D, Maggio A, Giambona A. Coheredity of a new silent mutation: c.-29G>T, with a severe β-thal mutation in a patient with β-thalassemia intermediate. Int J Lab Hematol 2018; 40:e17-e20. [PMID: 29405650 DOI: 10.1111/ijlh.12777] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2017] [Accepted: 12/21/2017] [Indexed: 11/29/2022]
Affiliation(s)
- M Vinciguerra
- Laboratory for Molecular Diagnosis of rare Diseases, Department of Hematology for Rare Diseases of Blood and Blood-forming Organs, Villa Sofia-Cervello Hospital, Palermo, Italy
| | - C Passarello
- Laboratory for Molecular Diagnosis of rare Diseases, Department of Hematology for Rare Diseases of Blood and Blood-forming Organs, Villa Sofia-Cervello Hospital, Palermo, Italy
| | - F Cassarà
- Laboratory for Molecular Diagnosis of rare Diseases, Department of Hematology for Rare Diseases of Blood and Blood-forming Organs, Villa Sofia-Cervello Hospital, Palermo, Italy
| | - F Leto
- Laboratory for Molecular Diagnosis of rare Diseases, Department of Hematology for Rare Diseases of Blood and Blood-forming Organs, Villa Sofia-Cervello Hospital, Palermo, Italy
| | - M Cannata
- Laboratory for Molecular Diagnosis of rare Diseases, Department of Hematology for Rare Diseases of Blood and Blood-forming Organs, Villa Sofia-Cervello Hospital, Palermo, Italy
| | - G Calvaruso
- Laboratory for Molecular Diagnosis of rare Diseases, Department of Hematology for Rare Diseases of Blood and Blood-forming Organs, Villa Sofia-Cervello Hospital, Palermo, Italy
| | - D Renda
- Laboratory for Molecular Diagnosis of rare Diseases, Department of Hematology for Rare Diseases of Blood and Blood-forming Organs, Villa Sofia-Cervello Hospital, Palermo, Italy
| | - A Maggio
- Laboratory for Molecular Diagnosis of rare Diseases, Department of Hematology for Rare Diseases of Blood and Blood-forming Organs, Villa Sofia-Cervello Hospital, Palermo, Italy
| | - A Giambona
- Laboratory for Molecular Diagnosis of rare Diseases, Department of Hematology for Rare Diseases of Blood and Blood-forming Organs, Villa Sofia-Cervello Hospital, Palermo, Italy
| |
Collapse
|
16
|
Agrigento V, Barone R, Sclafani S, Di Maggio R, Sacco M, Maggio A, D'Alcamo E. Response to Alpha-Interferon Treatment of the Congenital Dyserythropoietic Anemia type I in Two Sicilian Beta Thalassemia Carriers. Indian J Hematol Blood Transfus 2017; 33:621-623. [PMID: 29075082 DOI: 10.1007/s12288-016-0765-9] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2016] [Accepted: 12/07/2016] [Indexed: 11/30/2022] Open
Abstract
Congenital dyserythropoietic anemia type I (CDAI) is an autosomal recessive inherited haematological disorder associated with moderate-to-severe anemia characterized by ineffective erythropoiesis with distinct morphological abnormalities in erythroid precursors. We present two case of congenital dyserythropoietic anemia type I in two Sicilian patients heterozygous for β0 39 globin gene cod 39 C > T with marked bone marrow abnormalities, responding to treatment with alpha interferon. The diagnosis was established using routine haematological and biochemical test, light and electron microscopy; molecular analysis of the CDAN1 gene associated to the CDAI disease was performed. The response to the treatment was monitored using the hemoglobin levels, the red cell count, the reticulocyte count and the transfusional requirement. This report points out the usefulness of the treatment with interferon alpha in two Sicilian beta thalassemia carriers, in which the therapy was well tolerated without producing any side effects; in these patients the transfusion requirements after the initiation of interferon therapy decreased.
Collapse
Affiliation(s)
- V Agrigento
- U.O.C. Ematologia per le Malattie Rare del Sangue e degli Organi Ematopoietici, Azienda Ospedali Riuniti Villa Sofia-Cervello, Via Trabucco n. 180, 90146 Palermo, Italy
| | - R Barone
- U.O.C. Ematologia per le Malattie Rare del Sangue e degli Organi Ematopoietici, Azienda Ospedali Riuniti Villa Sofia-Cervello, Via Trabucco n. 180, 90146 Palermo, Italy
| | - S Sclafani
- U.O.C. Ematologia per le Malattie Rare del Sangue e degli Organi Ematopoietici, Azienda Ospedali Riuniti Villa Sofia-Cervello, Via Trabucco n. 180, 90146 Palermo, Italy
| | - R Di Maggio
- U.O.C. Ematologia per le Malattie Rare del Sangue e degli Organi Ematopoietici, Azienda Ospedali Riuniti Villa Sofia-Cervello, Via Trabucco n. 180, 90146 Palermo, Italy
| | - M Sacco
- U.O.C. Ematologia per le Malattie Rare del Sangue e degli Organi Ematopoietici, Azienda Ospedali Riuniti Villa Sofia-Cervello, Via Trabucco n. 180, 90146 Palermo, Italy
| | - A Maggio
- U.O.C. Ematologia per le Malattie Rare del Sangue e degli Organi Ematopoietici, Azienda Ospedali Riuniti Villa Sofia-Cervello, Via Trabucco n. 180, 90146 Palermo, Italy
| | - E D'Alcamo
- U.O.C. Ematologia per le Malattie Rare del Sangue e degli Organi Ematopoietici, Azienda Ospedali Riuniti Villa Sofia-Cervello, Via Trabucco n. 180, 90146 Palermo, Italy
| |
Collapse
|
17
|
Maggio A, Gabriele D, Garibaldi E, Bresciani S, Delmastro E, Di Dia A, Miranti A, Poli M, Varetto T, Stasi M, Gabriele P. Impact of a rectal and bladder preparation protocol on prostate cancer outcome in patients treated with external beam radiotherapy. Strahlenther Onkol 2017. [PMID: 28620751 DOI: 10.1007/s00066-017-1163-4] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
Abstract
PURPOSE AND OBJECTIVE To test the hypothesis that a rectal and bladder preparation protocol is associated with an increase in prostate cancer specific survival (PCSS), clinical disease free survival (CDFS) and biochemical disease free survival (BDFS). PATIENTS AND METHODS From 1999 to 2012, 1080 prostate cancer (PCa) patients were treated with three-dimensional conformal radiotherapy (3DCRT). Of these patients, 761 were treated with an empty rectum and comfortably full bladder (RBP) preparation protocol, while for 319 patients no rectal/bladder preparation (NRBP) protocol was adopted. RESULTS Compared with NRBP patients, patients with RBP had significantly higher BDFS (64% vs 48% at 10 years, respectively), CDFS (81% vs 70.5% at 10 years, respectively) and PCSS (95% vs 88% at 10 years, respectively) (log-rank test p < 0.001). Multivariate analysis (MVA) indicated for all treated patients and intermediate high-risk patients that the Gleason score (GS) and the rectal and bladder preparation were the most important prognostic factors for PCSS, CDFS and BDFS. With regard to high- and very high-risk patients, GS, RBP, prostate cancer staging and RT dose were predictors of PCSS, CDFS and BDFS in univariate analysis (UVA). CONCLUSION We found strong evidence that rectal and bladder preparation significantly decreases biochemical and clinical failures and the probability of death from PCa in patients treated without daily image-guided prostate localization, presumably since patients with RBP are able to maintain a reproducibly empty rectum and comfortably full bladder across the whole treatment compared with NRPB patients.
Collapse
Affiliation(s)
- A Maggio
- Medical Physic Department, Candiolo Cancer Institute - FPO,IRCCS, Candiolo (To), Italy.
| | - D Gabriele
- Radiotherapy Department, Candiolo Cancer Institute - FPO,IRCCS, Candiolo (To), Italy.,Division of Radiation Oncology, University of Sassari, Sassari, Italy
| | - E Garibaldi
- Radiotherapy Department, Candiolo Cancer Institute - FPO,IRCCS, Candiolo (To), Italy
| | - S Bresciani
- Medical Physic Department, Candiolo Cancer Institute - FPO,IRCCS, Candiolo (To), Italy
| | - E Delmastro
- Radiotherapy Department, Candiolo Cancer Institute - FPO,IRCCS, Candiolo (To), Italy
| | - A Di Dia
- Medical Physic Department, Candiolo Cancer Institute - FPO,IRCCS, Candiolo (To), Italy
| | - A Miranti
- Medical Physic Department, Candiolo Cancer Institute - FPO,IRCCS, Candiolo (To), Italy
| | - M Poli
- Medical Physic Department, Candiolo Cancer Institute - FPO,IRCCS, Candiolo (To), Italy
| | - T Varetto
- Nuclear Medicine Department, Candiolo Cancer Institute - FPO,IRCCS, Candiolo (To), Italy
| | - M Stasi
- Medical Physic Department, Candiolo Cancer Institute - FPO,IRCCS, Candiolo (To), Italy
| | - P Gabriele
- Radiotherapy Department, Candiolo Cancer Institute - FPO,IRCCS, Candiolo (To), Italy
| |
Collapse
|
18
|
Sini C, Noris Chiorda B, Gabriele P, Sanguineti G, Morlino S, Badenchini F, Cante D, Carillo V, Gaetano M, Giandini T, Landoni V, Maggio A, Perna L, Petrucci E, Sacco V, Valdagni R, Rancati T, Fiorino C, Cozzarini C. PO-0846: Bowel dose-volume relationship for patientreported acute intestinal toxicity from pelvic IMRT. Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)31283-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
19
|
Bresciani S, Garello A, Miranti A, Maggio A, Di Dia A, Gabriele P, Stasi M. EP-1662: Interfractional trend analysis of sinograms: a decision-making for adaptive radiotherapy. Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)32194-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
20
|
Broggi S, Galla A, Saracino B, Faiella A, Fossati N, Gabriele D, Gabriele P, Maggio A, Sanguineti G, Di Muzio N, Briganti A, Cozzarini C, Fiorino C. PO-0852: External validation of a TCP model predicting PSA relapse after post-prostatectomy Radiotherapy. Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)31289-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
21
|
Gabriele P, Maggio A, Garibaldi E, Bracco C, Delmastro E, Gabriele D, Rosi A, Munoz F, Di Muzio N, Corvò R, Stasi M. Quality indicators in the intensity modulated/image-guided radiotherapy era. Crit Rev Oncol Hematol 2016; 108:52-61. [DOI: 10.1016/j.critrevonc.2016.10.013] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2015] [Revised: 08/24/2016] [Accepted: 10/26/2016] [Indexed: 10/20/2022] Open
|
22
|
D'Alcamo E, Agrigento V, Pitrolo L, Sclafani S, Barone R, Calvaruso G, Buffa V, Maggio A. New Codanin-1 Gene Mutations in a Italian Patient with Congenital Dyserythropoietic Anemia Type I and Heterozygous Beta-Thalassemia. Indian J Hematol Blood Transfus 2016; 32:278-81. [PMID: 27408412 DOI: 10.1007/s12288-015-0633-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2015] [Accepted: 12/16/2015] [Indexed: 11/26/2022] Open
Abstract
Congenital dyserythropoietic anemia type I is an autosomal recessive disorder associated with macrocytic anemia, ineffective erythropoiesis, iron overloading and characterized by abnormal chromatin ultrastructure in erythroblasts such as internuclear chromatin bridges, spongy heterochromatin and invagination of the nuclear membrane. A 58-year-old Causasian man with chronic hemolytic anemia, heterozygous for β (+) -globin IVS1, nt110 G>A mutation (causing abnormal alpha:beta globin chain ratio) showed clinical, laboratory and hematological features suggesting diagnosis of CDA1. Sequence analysis of CDA-related genes revealed compound heterozygosity for two novel mutations in the CDAN1 gene: a frameshift mutation 3367 del 4 (TTAG) in exon 25 and a missense mutation c.1811 G>T in exon 11 causing an aminoacid change from glycine to valine at codon 565 (G565V). One of the propositus' brothers showed the same gene mutations. As the CDA1 can mimic thalassemia, a frequent misdiagnosis is possible especially in countries where the prevalence of thalassemia is high. A strong clinical suspicion in patients who do not reveal a clear genetic basis for presumed thalassemia may help clinch the correct diagnosis.
Collapse
Affiliation(s)
- Elena D'Alcamo
- Ospedale V. Cervello UOC Ematologia per le Malattie Rare del Sangue e degli Organi Ematopoietici, Azienda Ospedali Riuniti Villa Sofia-Cervello, Via Trabucco n° 180, 90146 Palermo, Italy
| | - V Agrigento
- Ospedale V. Cervello UOC Ematologia per le Malattie Rare del Sangue e degli Organi Ematopoietici, Azienda Ospedali Riuniti Villa Sofia-Cervello, Via Trabucco n° 180, 90146 Palermo, Italy
| | - L Pitrolo
- Ospedale V. Cervello UOC Ematologia per le Malattie Rare del Sangue e degli Organi Ematopoietici, Azienda Ospedali Riuniti Villa Sofia-Cervello, Via Trabucco n° 180, 90146 Palermo, Italy
| | - S Sclafani
- Ospedale V. Cervello UOC Ematologia per le Malattie Rare del Sangue e degli Organi Ematopoietici, Azienda Ospedali Riuniti Villa Sofia-Cervello, Via Trabucco n° 180, 90146 Palermo, Italy
| | - R Barone
- Ospedale V. Cervello UOC Ematologia per le Malattie Rare del Sangue e degli Organi Ematopoietici, Azienda Ospedali Riuniti Villa Sofia-Cervello, Via Trabucco n° 180, 90146 Palermo, Italy
| | - G Calvaruso
- Ospedale V. Cervello UOC Ematologia per le Malattie Rare del Sangue e degli Organi Ematopoietici, Azienda Ospedali Riuniti Villa Sofia-Cervello, Via Trabucco n° 180, 90146 Palermo, Italy
| | - V Buffa
- Ospedale V. Cervello UOC Ematologia per le Malattie Rare del Sangue e degli Organi Ematopoietici, Azienda Ospedali Riuniti Villa Sofia-Cervello, Via Trabucco n° 180, 90146 Palermo, Italy
| | - A Maggio
- Ospedale V. Cervello UOC Ematologia per le Malattie Rare del Sangue e degli Organi Ematopoietici, Azienda Ospedali Riuniti Villa Sofia-Cervello, Via Trabucco n° 180, 90146 Palermo, Italy
| |
Collapse
|
23
|
Pecoraro A, Troia A, Sacco M, Maggio A, Di Marzo R, Gioia M. Evaluation of IPF counting on Mindray BC-6800 hematology analyzer. Int J Lab Hematol 2016; 38:e89-92. [PMID: 27321672 DOI: 10.1111/ijlh.12524] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Affiliation(s)
- A Pecoraro
- U.O.C. Ematologia per le Malattie Rare del Sangue e degli Organi Ematopoietici, Azienda Ospedaliera 'Ospedali Riuniti Villa Sofia-Cervello', Palermo, Italy.
| | - A Troia
- U.O.C. Ematologia per le Malattie Rare del Sangue e degli Organi Ematopoietici, Azienda Ospedaliera 'Ospedali Riuniti Villa Sofia-Cervello', Palermo, Italy
| | - M Sacco
- U.O.C. Ematologia per le Malattie Rare del Sangue e degli Organi Ematopoietici, Azienda Ospedaliera 'Ospedali Riuniti Villa Sofia-Cervello', Palermo, Italy
| | - A Maggio
- U.O.C. Ematologia per le Malattie Rare del Sangue e degli Organi Ematopoietici, Azienda Ospedaliera 'Ospedali Riuniti Villa Sofia-Cervello', Palermo, Italy
| | - R Di Marzo
- U.O.C. Ematologia per le Malattie Rare del Sangue e degli Organi Ematopoietici, Azienda Ospedaliera 'Ospedali Riuniti Villa Sofia-Cervello', Palermo, Italy
| | - M Gioia
- U. O. C. Patologia Clinica, Azienda Ospedaliera 'Ospedali Riuniti Villa Sofia-Cervello', Palermo, Italy
| |
Collapse
|
24
|
Bresciani S, Poli M, Miranti A, Maggio A, Di Dia A, Bracco C, Stasi M. EP-1586: Characterization of a new EPID-based system for in-vivo dosimetry in VMAT treatments. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)32836-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
25
|
Stasi M, Bresciani S, Miranti A, Poli M, Di Dia A, Maggio A, Delmastro E, Gabriele P. EP-1587: Sensitivity and specificity of gamma index method for Tomotherapy plans. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)32837-7] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
26
|
Di Dia A, Depalma S, Bresciani S, Maggio A, Miranti A, Poli M, Gabriele P, Garibaldi E, Stasi M. PO-0945: Modeling and simulation of simultaneous using of two superficial hyperthermia antennas. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)32195-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
27
|
Palorini F, Rancati T, Cicchetti A, Improta I, Cozzarini C, Casanova Borca V, Degli Esposti C, Franco P, Garibaldi E, Girelli G, Maggio A, Micera R, Palombarini M, Pierelli A, Pignoli E, Simoni N, Vavassori V, Villa S, Valdagni R, Fiorino C. PO-0875: Multivariable models for urinary symptoms at 6-24 months after radical RT of prostate cancer. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)32125-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
28
|
Poli M, Bresciani S, Miranti A, Dia AD, Maggio A, Gatti M, Gabriele P, Stasi M. EP-1880: Validation of the use of digital camera for the prediction of skin toxicity in breast radiotherapy. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)33131-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
29
|
Gatti M, Belli G, Salatino A, Maggio A, Cattari G, Squintu S, Rivolin A, Ponzone R, Gabriele P. EP-1167: Radiation therapy and breast reconstruction: outcomes and complications in our experience. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)32417-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
30
|
Garibaldi E, Gabriele D, Maggio A, Garibaldi M, Delmastro E, Bresciani S, Sottile A, Stasi M, Gabriele P. EP-1361: Prognostic factors in 1080 prostate cancer treated with radical external beam radiotherapy. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)32611-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
31
|
Maggio A, Garibaldi E, Gabriele D, Bresciani S, Delmastro E, Di Dia A, Miranti A, Poli M, Gabriele P, Stasi M. PO-0752: Outcome of prostate cancer patients treated with 3DCRT: impact of rectal/bladder preparation. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)32002-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
32
|
Bresciani S, Poli M, Miranti A, Maggio A, Di Dia A, Bracco C, Stasi M. Characterization and comparison of two EPID-based software solutions for in-vivo dosimetry of VMAT treatments. Phys Med 2016. [DOI: 10.1016/j.ejmp.2016.01.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
33
|
Palorini F, Rancati T, Cicchetti A, Improta I, Cozzarini C, Borca VC, Degli Esposti C, Franco P, Garibaldi E, Girelli G, Maggio A, Botti A, Palombarini M, Pierelli A, Pignoli E, Simoni N, Vavassori V, Villa S, Valdagni R, Fiorino C. Clinical and dose predictors for the incidence of late urinary symptoms after radical radiotherapy for prostate cancer. Phys Med 2016. [DOI: 10.1016/j.ejmp.2016.01.170] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
34
|
Poli M, Bracco C, Bresciani S, Maggio A, Di Dia A, Miranti A, Stasi M. Three years of experience with dose reduction by means of iterative reconstruction algorithm available on CT Siemens Somatom Definition Flash. Phys Med 2016. [DOI: 10.1016/j.ejmp.2016.01.300] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
35
|
Maggio A, Garibaldi E, Gabriele D, Bresciani S, Delmastro E, Di Dia A, Miranti A, Poli M, Gabriele P, Stasi M. Is the outcome of prostate cancer patients treated with 3D conformal radiotherapy influenced by rectal/bladder preparation? Phys Med 2016. [DOI: 10.1016/j.ejmp.2016.01.136] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
36
|
Giambona A, Damiani G, Vinciguerra M, Jakil C, Cannata M, Cassarà F, Picciotto F, Schillaci G, Cigna V, Renda D, Leto F, Passarello C, Maggio A. Incidence of haemoglobinopathies in Sicily: the impact of screening and prenatal diagnosis. Int J Clin Pract 2015; 69:1129-38. [PMID: 25727926 DOI: 10.1111/ijcp.12628] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
Abstract
BACKGROUND Haemoglobinopathies are a major public health problem in Sicily: it was estimated a frequency of 1/245 couples are at risk of haemoglobinopathies. This paper reviews legislative actions, prevention activities, carrier screening, genetic counselling, foetal sampling and laboratory methodology analysis evolution reporting the results of 30 years of prevention actions to assess the efficiency of our preventative programme in the control of haemoglobinopathies in Sicily. METHODS This programme consisted principally of five phases: legislative actions, public awareness campaign, carrier screening, genetic counselling and prenatal diagnosis. RESULTS These programmes have been very effective, which we can see from a greater public awareness of thalassaemia and its prevention in the target population furthermore by a marked decline in the incidence of thalassaemia major and sickle cell anaemia from 1 in 245 live births in the absence of prevention to 1 in 2000, with a reduction in about 85%. The residual cases were because of a conscious choice by expecting parents in relation to improved life expectancy as well as improved quality of life of the affected patients. CONCLUSION The study suggests that public health authorities should act and invest in a similar programme for prevention of thalassaemia, as well as in relation to the increased survival of patients and the consequent organ complications.
Collapse
Affiliation(s)
- A Giambona
- Department of Hematology for Rare Diseases of Blood and Blood-forming Organs, Laboratory for Molecular Prenatal of Hemoglobinipathies, Villa Sofia-Cervello Hospital, Palermo, Italy
| | - G Damiani
- U.O.C. of Gynecology and Obstetrics, U.O.S. Prenatal Diagnosis, A.O.R. Villa Sofia-Cervello Hospital, Palermo, Italy
| | - M Vinciguerra
- Department of Hematology for Rare Diseases of Blood and Blood-forming Organs, Laboratory for Molecular Prenatal of Hemoglobinipathies, Villa Sofia-Cervello Hospital, Palermo, Italy
| | - C Jakil
- U.O.C. of Gynecology and Obstetrics, U.O.S. Prenatal Diagnosis, A.O.R. Villa Sofia-Cervello Hospital, Palermo, Italy
| | - M Cannata
- Department of Hematology for Rare Diseases of Blood and Blood-forming Organs, Laboratory for Molecular Prenatal of Hemoglobinipathies, Villa Sofia-Cervello Hospital, Palermo, Italy
| | - F Cassarà
- Department of Hematology for Rare Diseases of Blood and Blood-forming Organs, Laboratory for Molecular Prenatal of Hemoglobinipathies, Villa Sofia-Cervello Hospital, Palermo, Italy
| | - F Picciotto
- U.O.C. of Gynecology and Obstetrics, U.O.S. Prenatal Diagnosis, A.O.R. Villa Sofia-Cervello Hospital, Palermo, Italy
| | - G Schillaci
- U.O.C. of Gynecology and Obstetrics, U.O.S. Prenatal Diagnosis, A.O.R. Villa Sofia-Cervello Hospital, Palermo, Italy
| | - V Cigna
- U.O.C. of Gynecology and Obstetrics, U.O.S. Prenatal Diagnosis, A.O.R. Villa Sofia-Cervello Hospital, Palermo, Italy
| | - D Renda
- Department of Hematology for Rare Diseases of Blood and Blood-forming Organs, Laboratory for Molecular Prenatal of Hemoglobinipathies, Villa Sofia-Cervello Hospital, Palermo, Italy
| | - F Leto
- Department of Hematology for Rare Diseases of Blood and Blood-forming Organs, Laboratory for Molecular Prenatal of Hemoglobinipathies, Villa Sofia-Cervello Hospital, Palermo, Italy
| | - C Passarello
- Department of Hematology for Rare Diseases of Blood and Blood-forming Organs, Laboratory for Molecular Prenatal of Hemoglobinipathies, Villa Sofia-Cervello Hospital, Palermo, Italy
| | - A Maggio
- Department of Hematology for Rare Diseases of Blood and Blood-forming Organs, Laboratory for Molecular Prenatal of Hemoglobinipathies, Villa Sofia-Cervello Hospital, Palermo, Italy
| |
Collapse
|
37
|
Vinciguerra M, Passarello C, Cassarà F, Leto F, Cannata M, Calvaruso G, Di Maggio R, Renda D, Maggio A, Giambona A. Co-heredity of silent CAP + 1570 T>C (HBB:c*96T>C) defect and severe β-thal mutation: a cause of mild β-thalassemia intermedia. Int J Lab Hematol 2015; 38:17-26. [PMID: 26418075 DOI: 10.1111/ijlh.12433] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2015] [Accepted: 08/05/2015] [Indexed: 11/29/2022]
Abstract
INTRODUCTION During an intensive screening program aimed at identifying the healthy carriers of thalassemia and the couples at risk of bearing an affected fetus, a rare single nucleotide variation (SNV), CAP + 1570 T > C (HBB:c*96T > C), located 12 nucleotides upstream of the polyadenylation signal in 3'UTR of the beta globin gene was identified. It was previously reported as a β+ thalassemia mutation and later as a plain polymorphism. METHODS Genotype identification of globin gene mutations was carried out using sequencing analysis, GAP-PCR, and MLPA methods. RESULTS CAP + 1570 T > C (HBB:c*96T > C) was found in 39 heterozygotes, in one case in homozygous state and in thirteen cases of co-inheritance of this nucleotide substitution with other mutations in globin genes. Carriers of this mutation showed a 'silent' phenotype without appreciable microcytosis and hypochromia, so they cannot be differentiated from noncarrier individuals. Compound heterozygotes for this mutation and severe β-thal mutations showed a variable phenotype ranging from β-thal carrier to mild form of β-thalassemia intermedia, revealing new aspects and allowing to better understand the clinical implications of this nucleotide substitution that can be classified as a silent β-thalassemic defect. CONCLUSION Data reported in this study indicate the need of investigating partner of β-thalassemia carrier by complete sequencing analysis of β-globin gene and of providing an appropriate genetic counseling for couples at risk undergoing prenatal diagnosis.
Collapse
Affiliation(s)
- M Vinciguerra
- Department of Hematology for Rare Diseases of Blood and Blood-Forming Organs, Regional Reference Laboratory for Screening and Prenatal Diagnosis of Hemoglobinopathies, Villa Sofia-Cervello Hospital, Palermo, Italy
| | - C Passarello
- Department of Hematology for Rare Diseases of Blood and Blood-Forming Organs, Regional Reference Laboratory for Screening and Prenatal Diagnosis of Hemoglobinopathies, Villa Sofia-Cervello Hospital, Palermo, Italy
| | - F Cassarà
- Department of Hematology for Rare Diseases of Blood and Blood-Forming Organs, Regional Reference Laboratory for Screening and Prenatal Diagnosis of Hemoglobinopathies, Villa Sofia-Cervello Hospital, Palermo, Italy
| | - F Leto
- Department of Hematology for Rare Diseases of Blood and Blood-Forming Organs, Regional Reference Laboratory for Screening and Prenatal Diagnosis of Hemoglobinopathies, Villa Sofia-Cervello Hospital, Palermo, Italy
| | - M Cannata
- Department of Hematology for Rare Diseases of Blood and Blood-Forming Organs, Regional Reference Laboratory for Screening and Prenatal Diagnosis of Hemoglobinopathies, Villa Sofia-Cervello Hospital, Palermo, Italy
| | - G Calvaruso
- Department of Hematology for Rare Diseases of Blood and Blood-Forming Organs, Regional Reference Laboratory for Screening and Prenatal Diagnosis of Hemoglobinopathies, Villa Sofia-Cervello Hospital, Palermo, Italy
| | - R Di Maggio
- Department of Hematology for Rare Diseases of Blood and Blood-Forming Organs, Regional Reference Laboratory for Screening and Prenatal Diagnosis of Hemoglobinopathies, Villa Sofia-Cervello Hospital, Palermo, Italy
| | - D Renda
- Department of Hematology for Rare Diseases of Blood and Blood-Forming Organs, Regional Reference Laboratory for Screening and Prenatal Diagnosis of Hemoglobinopathies, Villa Sofia-Cervello Hospital, Palermo, Italy
| | - A Maggio
- Department of Hematology for Rare Diseases of Blood and Blood-Forming Organs, Regional Reference Laboratory for Screening and Prenatal Diagnosis of Hemoglobinopathies, Villa Sofia-Cervello Hospital, Palermo, Italy
| | - A Giambona
- Department of Hematology for Rare Diseases of Blood and Blood-Forming Organs, Regional Reference Laboratory for Screening and Prenatal Diagnosis of Hemoglobinopathies, Villa Sofia-Cervello Hospital, Palermo, Italy
| |
Collapse
|
38
|
Stasi M, Bresciani S, Miranti A, Di Dia A, Maggio A, Dispirito D. PO-0846: A retrospective analysis of 384 Tomotherapy per-patient verifications. Radiother Oncol 2015. [DOI: 10.1016/s0167-8140(15)40838-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
39
|
Palorini F, Rancati T, Cozzarini C, Carillo V, Casanova Borca V, Degli Esposti C, Franco P, Garibaldi E, Girelli E, Maggio A, Micera R, Palombarini M, Pierelli A, Pignoli E, Simoni N, Vavassori V, Villa S, Valdagni R, Fiorino C. OC-0255: Multi-variable models of acute urinary toxicity: final results of a large prospective study. Radiother Oncol 2015. [DOI: 10.1016/s0167-8140(15)40253-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
40
|
F. Pane SC, Maggio A. Abstract book. Thal Rep 2014. [DOI: 10.4081/thal.2014.s1.abs] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
|
41
|
Pane F, Maggio A. Abstract Book. Thalassemia Reports 2014. [DOI: 10.4081/thal.2014.4725] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
Relapsed/refractory AML patients have a poor prognosis, with CR rates of 1–30%, unless allogeneic hematopoietic stem cell transplantation (HSCT) is an available option [...]
Collapse
|
42
|
Carillo V, Botti A, Casanova Borca V, Cattari G, Civardi F, Cozzarini C, Degli Esposti C, Fiorino C, Franco P, Girelli G, Maggio A, Muraglia A, Palombarini M, Pierelli A, Pignoli E, Rancati T, Valdagni R, Vavassori V, Villa S, Zeverino M. 41: Modelling acute urinary toxicity after radiotherapy for prostate cancer. Radiother Oncol 2014. [DOI: 10.1016/s0167-8140(15)34062-7] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
43
|
Gregory SG, Holzwarth VR, Donati JF, Hussain GAJ, Montmerle T, Alecian E, Alencar SHP, Argiroffi C, Audard M, Bouvier J, Damiani F, Güdel M, Huenemoerder DP, Kastner JH, Maggio A, Sacco GG, Wade GA. The magnetosphere of the close accreting PMS binary V4046 Sgr. EPJ Web of Conferences 2014. [DOI: 10.1051/epjconf/20136408009] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
44
|
Bresciani S, Miranti A, Maggio A, Di Dia A, Stasi M. PO-0815: Pre-treatment IMRT quality assurance: from ROC curves to Quantec constraints. Radiother Oncol 2014. [DOI: 10.1016/s0167-8140(15)30933-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
45
|
Cutaia C, Maggio A, Garibaldi E, Bresciani S, Di Dia A, Cattari G, Del Mastro E, Gabriele P, Stasi M. PO-0980: Helical Tomotherapy dose-escalation feasability study for radical malignant pleural mesothelioma. Radiother Oncol 2014. [DOI: 10.1016/s0167-8140(15)31098-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
46
|
Cattari G, Garibaldi E, Cutaia C, Delmastro E, Maggio A, Bresciani S, Stasi M, Gabriele P. EP-1177: Pleural cavity radiotherapy with IMRT-SIB-IGRT by Tomotherapy for malignant pleural mesothelioma. Radiother Oncol 2014. [DOI: 10.1016/s0167-8140(15)31295-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
47
|
Gabriele P, Garibaldi E, Cattari G, Bracco C, Maggio A, Suma A, Petrilli G, Penduzzu G, Stasi M. EP-1432: New indicators for volumetric radiotherapy: A proposal. Radiother Oncol 2014. [DOI: 10.1016/s0167-8140(15)31550-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
48
|
Maggio A, Di Dia A, Bresciani S, Cutaia C, Miranti A, Stasi M. EP-1568: Dosimetric comparison between GPU and CPU cluster based Tomotherapy dose engine for different anatomical districts. Radiother Oncol 2014. [DOI: 10.1016/s0167-8140(15)31686-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
49
|
Jemia MB, Tundis R, Maggio A, Rosselli S, Senatore F, Menichini F, Bruno M, Kchouk M, Loizzo M. NMR-based quantification of rosmarinic and carnosic acids, GC–MS profile and bioactivity relevant to neurodegenerative disorders of Rosmarinus officinalis L. extracts. J Funct Foods 2013. [DOI: 10.1016/j.jff.2013.09.008] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
50
|
Bresciani S, Cattari G, Garibaldi E, Di Dia A, Delmastro E, Maggio A, Stasi M, Gabriele P. EP-1202: Extended fields irradiation in the upper abdomen with Tomotherapy: planning optimization and dosimetric analysis. Radiother Oncol 2013. [DOI: 10.1016/s0167-8140(15)33508-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|